Purpose: To understand factors contributing to therapy success, this study investigated the role of parents' temperament and the fit between parents' temperament and parent-reported child behavior problems in therapy outcomes across two therapy types.

Method: A total of 177 children who stutter and their parents were included in this study. Data from 149 children were present at the follow-up. Children received either Lidcombe Program (LP) or Rotterdam Evaluation Study of Stuttering Therapy randomized trial-Demands and Capacities Model (RESTART-DCM) therapy. Parents' temperaments and children's behaviors were measured at baseline. At 18 months of therapy postonset (T4) and 5 years later (T5), the children's remittance or persistence in stuttering was assessed.

Results: High parental novelty seeking and high harm avoidance were associated with transient stuttering at T4 in the entire sample. Looking across therapies, novelty seeking remained significant in the RESTART-DCM group at T4, whereas in the LP group, significant associations were observed for reward dependence (at T4 and T5) and persistence (at T4). Meanwhile, none of the parent-child fits were associated with therapy outcome.

Conclusions: The results suggest that for preschoolers receiving treatment, parents who tend to seek novelty and exploration, as well as those with greater vigilance toward harm, have a positive impact on therapy success. In contrast, socially dependent parents might have a negative impact on therapy success in children receiving LP treatment, whereas diligent parents could serve as a protective factor in this therapy. These exploratory results should be interpreted with caution, and future research will be crucial to confirm and further interpret these results.

Download full-text PDF

Source
http://dx.doi.org/10.1044/2024_JSLHR-24-00062DOI Listing

Publication Analysis

Top Keywords

therapy success
12
therapy
11
stuttering therapy
8
children stutter
8
parents' temperament
8
novelty seeking
8
receiving treatment
8
impact therapy
8
children
5
role parental
4

Similar Publications

Dose selection is a critical process within pediatric drug development and dose-ranging studies are integral to establish a reasonable dose. The objective of this analysis was to examine the dose-ranging trials utilized in pediatric drug development and to determine (1) the dose-ranging strategies that were used in all available pediatric dose-ranging studies, (2) the success of achieving pediatric labeling in those submissions to the US Food and Drug Administration, and (3) ethical aspects of providing a prospect of direct benefit to pediatric patients in dose-ranging studies. Of the 275 programs that previously surveyed pediatric drug development programs from 2012 to 2020, it was determined that dose-ranging studies were used for 97 (35.

View Article and Find Full Text PDF

In recent years, the rapid progress in oncology, immunology, and molecular biology has dramatically advanced cancer immunotherapy, particularly CAR-T cell therapy. This innovative approach involves engineering a patient's T cells to express receptors that specifically target tumor antigens, enhancing their ability to identify and eliminate cancer cells. However, the effectiveness of CAR-T therapy in solid tumors is often hampered by the challenging tumor microenvironment (TME).

View Article and Find Full Text PDF

Background: Tisagenlecleucel, an autologous CD19-directed chimeric antigen receptor T-cell therapy, was approved in Japan, in March 2019 for patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukamia and r/r diffuse large B-cell lymphoma, and in August 2022 for patients with r/r follicular lymphoma. Post-approval, a key goal has been to upscale and continuously improve manufacturing and shipment success rates (MSR and SSR, respectively) in the commercial setting to meet the needs of patients worldwide, including in Japan. Herein, we report accrued experience from a 4-year journey of commercial tisagenlecleucel manufacturing process optimization for patients in Japan.

View Article and Find Full Text PDF

Pheochromocytomas present with paroxysmal hypertension due to a sudden release of catecholamines stimulated by radiological contrast media, surgery, or anesthetic agents. This often complicates the maintenance of patient hemodynamics during surgery. A 55-year-old man with a high fever was admitted to a hospital.

View Article and Find Full Text PDF

Left ventricular assist devices (LVADs) serve as critical life-sustaining therapy for patients with end-stage heart failure awaiting heart transplantation, significantly improving survival rates and enabling social reintegration. However, many patients with LVAD face multiple challenges in their daily lives and social reintegration, such as anxiety about the device, low societal awareness, and economic and psychological burdens. In Japan, where prolonged waiting periods for heart transplants are inevitable, these challenges further exacerbate the economic and psychological burdens on both patients and caregivers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!